Navigation Links
Pathology Reports Good for Breast Cancer Studies
Date:2/7/2008

Harvard docs say this way of checking estrogen-receptor status of participants is OK

THURSDAY, Feb. 7 (HealthDay News) -- In epidemiological studies of women with breast cancer, pathology reports offer an acceptable alternative to repeated central laboratory testing for determining the estrogen-receptor status of participants, new research suggests.

The use of pathology reports is common practice in such studies, but it wasn't known whether they were accurate, according to the report in a recent issue of the Journal of the National Cancer Institute. Misclassification of estrogen-receptor status could seriously affect study results.

In this study, researchers at Beth Israel Deaconess Medical Center in Boston assessed the reliability of estrogen-receptor results in pathology reports by comparing them to the results of tests performed by a central laboratory.

The results were the same for 1,615 (87.3 percent) of the 1,851 samples checked in the study. This is a high rate of agreement, according to the researchers.

"Our findings, therefore, indicate that using [estrogen-receptor] assay results from pathology reports is a reasonable alternative to using central laboratory testing to obtain [estrogen- receptor] results in large, population-based studies of women with breast cancer," the study authors concluded.

More information

The American Cancer Society has more about breast cancer.



-- Robert Preidt



SOURCE: Journal of the National Cancer Institute news release, Jan. 29, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Congressman Hoekstra Tours Holland Pathology Laboratory; Learns Vital Role In Patient Care
2. Congressman Davis to Tour Pathology Laboratory, Learn Critical Role in Patient Care
3. Springer founds new electronic journal Head and Neck Pathology
4. Xceed Molecular Launches Ziplex(R) Automated Gene-Expression System at the Association for Molecular Pathology, Booth 84/85
5. Leaders in Pathology Meet in Chicago: Sept. 30 - Oct. 3, 2007
6. American Pacific Reports Revenue Increase of 34% and Net Income of $2.9 Million for Fiscal 2008 First Quarter
7. J.D. Power and Associates Reports: The Nebraska Medical Center Recognized for Providing an Outstanding Inpatient Experience for a Third Consecutive Year, and for Providing an Outstanding Cardiovascular Experience
8. HCA Reports Fourth Quarter - Year End 2007 Results
9. MedCath Corporation Reports First Quarter Earnings
10. DRAXIS Health Reports Fourth Quarter and Year End Results
11. PPD Reports Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pathology Reports Good for Breast Cancer Studies
(Date:6/26/2016)... Charlotte, NC (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind ... able to be personalized through a fitness app. The fitness app plans to fix the ... solutions currently only offer a one size fits all type program , They ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... , , , WHEN: ... , , , , LOCATION: , , , Online, with ... , EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice ... Senior Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... industry is witnessing an exceptional era. Several new demand spaces, such ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology: